Skip to Content

Endurance RP Ltd RPGLF Stock Quote

| Rating as of

Morningstar‘s Stock Analysis RPGLF

Currency in USD
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price


5-Star Price


Economic Moat


About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Key Statistics RPGLF

Company Profile RPGLF

Business Description

Endurance RP Ltd is an investment holding company. The company runs through two segments: Biopharma and Corporate Investment. Its Biopharma segment is engaged in the research, development, manufacturing, marketing, and sales of pharmaceutical products, and it also develops artificial intelligence (AI) systems for the field of biological aging clocks. The Corporate Investment segment is engaged in the investment in listed and unlisted corporate entities. The majority of its revenue comes from the Biopharma segment. Its geographical segments are China, Europe, Hong Kong, and Taiwan.

5 Queen's Road Central, 8th Floor, Henley Building
Hong Kong, Hong Kong
T +852 25146111
Industry Asset Management
Most Recent Earnings
Fiscal Year End Dec 31, 2022
Stock Type
Employees 18